Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

ABT199/venetoclax potentiates the cytotoxicity of alkylating agents and fludarabine in acute myeloid leukemia cells

Oncotarget(2022)10.18632/oncotarget.28193Source: DataRank Database

ABT199/venetoclax potentiates the cytotoxicity of alkylating agents and fludarabine in acute myeloid leukemia cells is a research paper published in Oncotarget (2022). On theSindex it has a DataRank of 0. It has been cited 15 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access15 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)OA: goldTopics (43)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

David Murray ORCID,Bin Yuan ORCID,Yago Nieto ORCID,Uday Popat ORCID,Börje S. Andersson ORCID

Live enrichment

PubMed:35154579 PMC:PMC8830224

NCI NIH HHS

Grant: P30 CA016672

goldLicense: cc-by

publisherhttps://www.oncotarget.com/article/28193/pdf/

publisherhttps://www.oncotarget.com/lookup/doi/10.18632/oncotarget.28193

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8830224

Europe_PMChttps://europepmc.org/articles/PMC8830224

Europe_PMChttps://europepmc.org/articles/PMC8830224?pdf=render

Fields of Study

AMP-Activated Protein KinasesAlkylating AgentsAntineoplastic AgentsBridged Bicyclo Compounds, HeterocyclicBusulfanCaspase 3Drug CombinationsHematopoietic Stem Cell TransplantationHumansLeukemia, Myeloid, AcuteMyeloid Cell Leukemia Sequence 1 ProteinNucleosidesPhosphatidylinositol 3-KinasesReactive Oxygen SpeciesSTAT5 Transcription FactorSulfonamidesTransplantation ConditioningVidarabinebeta Catenin

MeSH Terms

HumansReactive Oxygen SpeciesBusulfanSulfonamidesNucleosidesVidarabineAntineoplastic AgentsDrug CombinationsAlkylating AgentsTransplantation ConditioningHematopoietic Stem Cell TransplantationSTAT5 Transcription Factorbeta CateninCaspase 3Leukemia, Myeloid, AcuteAMP-Activated Protein KinasesPhosphatidylinositol 3-KinasesMyeloid Cell Leukemia Sequence 1 ProteinBridged Bicyclo Compounds, Heterocyclic

Keywords

CyclophosphamideAcute myeloid leukemiaBusulfanfludarabineAbt199/venetoclax